Table 3 Clinical characteristics of genotyped samples from the pediatric cohort of asthma. (FEV1 : Forced Expiratory Volume in one second,  FVC : Forced vital capacity, MEF25: Maximum expiratory flow at 25% of FVC,  MEF75 :  Maximum expiratory flow at 75% of FVC, PEFR : Peak expiratory flow rate, A: ANOVA, K: Kruskal Wallis).

From: Genetic variations in olfactory receptor gene OR2AG2 in a large multigenerational family with asthma

VariableGG (n = 57)GC (n = 58)CC (n = 26)Statistical Test
Mean (SD)Mean (SD)Mean (SD)p-value *(A/K)
Age (Months)106.88 (42.09)101.36 (38.20)106.50 (38.36)0.73 (A)
Exhaled Nitric Oxide (PPB)24.65 (19.66)18.89 (11.95)16.77 (9.56)0.28 (K)
FEV1 (% predicted)89.2 (18.76)83.28 (19.02)83.33 (17.70)0.27 (A)
FVC (% predicted)86.96 (15.99)81.93 (16.34)82.10 (17.48)0.30 (A)
MEF25 (% predicted)79.43 (48.19)77.86 (40.62)89.57 (48.24)0.75 (K)
MEF75 (% predicted)91.58 (29.69)84.32 (30.25)84.67 (29.83)0.47 (A)
PEFR (% predicted)74.48 (20.65)67.43 (24.14)69.05 (20.07)0.29 (A)
Exacerbation Frequency0.13 (0.14)0.20 (0.22)0.16 (0.12)0.30 (K)
Smell Test PEA8.4 (3.09)7.04 (3.39)6.48 (3.63)0.19 (A)